• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • 704.376.3688
  • sbuchanan@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • Research
  • About NCSG
    • Board of Directors
    • Board Meetings
    • Grants
    • Partners
    • NCSG Bylaws
JOIN or RENEW HERE
✕
Categories
  • Eosinophilic Esophagitis
Tags
  • Eosinophilic Esophagitis

 

Study title A Randomized, Double-Blind, Placebo-Controlled Clinical Trial To Evaluate The Efficacy Of Dupilumab (Anti-Il4ra) In Subjects With Eosinophilic Gastritis (DEGAS)
Disease or condition Eosinophilic Gastritis
Study type Interventional (Clinical Trial)
Intervention/treatment Dupolumab or placebo
Phase 2
Study site University of North Carolina at Chapel Hill
Study location Chapel Hill
Principal investigator name and email Evan Dellon, MD, MPH cedas@med.unc.edu
Study coordinator name and email Wyatt Moorer, wwmoorer@email.unc.edu
Phone contact (919) 843-4480
Clinicaltrials.gov link https://clinicaltrials.gov/ct2/show/NCT03678545

ADDRESS


1112 Harding Place
Suite 100
Charlotte NC 28204

Fax: 704.376.3173

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


704.376.3688
sbuchanan@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN or RENEW HERE